Operating income of BioNTech 2017-2023
In 2023, the annual operating income of biotech company BioNTech SE was around 690 million euros, compared to around 12.6 billion euros in the previous year. This statistic illustrates the annual operating income of BioNTech from 2017 to 2023. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.